In order to ensure the ongoing safety of our patients and staff, please note that CAMH is maintaining the requirement for universal masking of staff, patients, visitors/essential care partners, contractors/vendors at CAMH. A hospital-approved mask will be required to enter into our buildings and in all common areas. Further, current screening stations and protocols are also being maintained and there will be no change in the requirement for anyone with COVID-19 symptoms or exposure risks to not enter the hospital.
Building on strong clinical services, we consider a strong and focused research program critical to our mission to improve care for older people with mental illnesses in Ontario. We work in partnership with scientific, clinical and administrative staff at CAMH, and with locally, nationally and internationally recognized neuroscientists and clinical scientists to study ways to improve interventions for older people with illnesses such as major depression, bipolar disorder, schizophrenia or dementia (Alzheimer's disease). Through the Azrieli Centre for Neurodevelopmental Disabilities and Mental Health, we study mental health and behaviour difficulties and interventions among adults with intellectual and developmental disabilities.
Impact on Patient Care
The overarching aim of our work is to improve our understanding of how treatments work, and the differences in response among patients, so that we can ultimately to improve and personalize care with medication, psychotherapy or brain stimulation. We also aim to enhance the effectiveness of these interventions, and reduce adverse experiences or side effects.
Research Focus & Projects
Our Research Program brings together seven approaches: ● Brain therapeutics ● Genetics ● Neuroimaging ● Neurophysiology ● Neuropsychology ● Pharmacology ● Psychosocial interventions.
Visit our Programs & Services Directory for information on our clinical services, including the Memory Clinic, Late-Life Mood and Schizophrenia Clinics and more.